Fungal Vascular Graft Infections, French Multicenter Retrospective Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
Fungal vascular graft and endograft infections (VGEIs) are rare but life-threatening infections. Best therapeutic management is unknown. This study retrospectively gathers fungal VGEIs from 12 university hospital centers in France over a 10 year's period in order to describe their epidemiology, clinical features, therapeutic management and outcomes. Focusing on Candida spp. VGEIs, we aim to determine prognosis factors associated with therapeutic management
Eligibility criteria
Qualifiers
Patients aged ≥ 18 years old with diagnosis of vascular graft and endograft infections (VGEI) in accordance to MAGIC criteria with diagnosis of proven invasive fungal infection according to EORTC criteria.
No opposition to re-use data.
Disqualifiers
Patient previously treated for fungal VGEI
Patient with suspected VGEI diagnosis based solely on prosthesis implantation in an infected site
Poor understanding of French.
Patient under legal protection.
Trial design
Treatments tested in this trial
- epidemiology and medical treatment strategies
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov